Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 554-562

  Bexfield, A ^a   Bond, A E ^a   Morgan, C ^a   Wagstaff, J ^a,b   Newton, R P ^a   Ratcliffe, N A ^a   Dudley, E ^a   Nigam, Y ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Amino acids; Angiogenesis; Maggot therapy; Metabolites

Indexed keywords

AMINO ACID DERIVATIVE; GUANIDINOPROPIONIC ACID; HISTIDINE; UNCLASSIFIED DRUG; VALINOL; AMINO ACID; ANTIINFECTIVE AGENT;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; FLY; HUMAN; HUMAN CELL; LUCILIA SERICATA; MAGGOT THERAPY; MASS SPECTROMETRY; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; THIN LAYER CHROMATOGRAPHY; WOUND HEALING; ANIMAL; BODILY SECRETIONS; DIPTERA; LARVA; METABOLISM; PHYSIOLOGY; WOUND INFECTION;

AMINO ACIDS; ANIMALS; ANTI-BACTERIAL AGENTS; BODILY SECRETIONS; CHROMATOGRAPHY, THIN LAYER; DIPTERA; HUMANS; LARVA; MASS SPECTROMETRY; WOUND HEALING; WOUND INFECTION;

EID: 76949097234     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09530.x     Document Type: Article

References (33)

1. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA. Maggot therapy: the science and implication for CAM Part I - History and bacterial resistance. Evid Based Complement Alternat Med 2006 3 : 223 227.
2. Sherman RA, Hall MJR, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000 45 : 55 81.
3. Mumcuoglu KY, Miller J, Mumcuoglu M et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001 38 : 161 166.
4. Bexfield A, Nigam Y, Thomas S, Ratcliffe NA. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus. Microbes Infect 2004 6 : 1297 1304.
5. Bexfield A, Bond AE, Roberts EC et al. The antibacterial activity against MRSA strains and other bacteria of a < 500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect 2008 10 : 325 333.
6. Nigam Y, Bexfield A, Thomas S, Ratclife NA. Maggot therapy: the science and implication for CAM Part II - Maggots combat infection. Evid Based Complement Alternat Med 2006 3 : 303 308.
7. Menke MN, Menke NB, Boardman CH et al. Biologic therapeutics and molecular profiling to optimize wound healing. Gynecol Oncol 2008 111 : S87 91.
8. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997 60 : 505 510.
9. Horobin AJ, Shakesheff KM, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005 13 : 422 433.
10. Smith AG, Powis RA, Pritchard DI, Britland ST. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds. Biotechnol Prog 2006 22 : 1690 1696.
11. Horobin AJ, Shakesheff KM, Woodrow S et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003 148 : 923 933.
12. Chambers L, Woodrow S, Brown AP et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003 148 : 14 23.
13. Pečivová J, Mačičková T, Takáč P et al. Effect of the extract from salivary glands of Lucilia sericata on human neutrophils. Neuro Endocrinol Lett 2008 29 : 794 797.
14. van der Plas MJA, ven der Does AM, Baldry M et al. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect 2007 9 : 507 514.
15. Chapman RF. Excretion and salt and water regulation. In : The Insects. Structure and Function, 4th edn. Cambridge : Cambridge University Press, 1998 478 508.
16. Robinson W. Stimulation of healing in non-healing wounds by allantoin in maggot secretions and of wide biological distribution. J Bone Joint Surg 1935 17 : 267 271.
17. Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. Am J Surg 1940 47 : 111 115.
18. Dumville JC, Worthy G, Bland JM et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009 338 : b773.
19. Dongoh H, Kim H-Y, Lee H-J et al. Wound healing activity of gamma-aminobutyric acid (GABA) in rats. J Microbiol Biotechnol 2007 17 : 1661 1669.
20. Favia G, Mariggio MA, Maiorano E et al. Accelerated wound healing of soft oral soft tissues and angiogenic effect induced by a pool of amino acids combined to sodium hyaluronate (AMINOGAM). J Biol Regul Homeost Agents 2008 22 : 109 116.
21. Rosenthal GA. Toxic constituents and their related metabolites. In : Plant Nonprotein Amino and Imino acids. Biological, Biochemical and Toxicological Properties (Rosenthal GA, ed). London : Academic Press, 1982 57 157.
22. Thomas S. Cost of managing chronic wounds in the UK, with particular emphasis on maggot debridement therapy. J Wound Care 2006 15 : 456 469.
23. Kerridge A, Lappin-Scott H, Stevens JR. Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Med Vet Entomol 2005 19 : 333 337.
24. Chin GA, Schultz GS, Chegini N et al. Biochemistry of wound healing in wound care practice. In : Wound Care Practice (Sheffield P ed 2nd edn. Flagstaff, AZ : Best Publishing Co., 2007.
25. Bondavalli F, Bruno O, Ranise A et al. 3,5-Diphenyl-1H-pyrazole derivatives IX. 2-Substituted 4-phenyl-5-(3,5-diphenyl-1H-pyrazole-1-yl) pyrimidines with platelet antiaggregating and other activities. Farmaco 1992 47 : 171 190.
26. Lillie JW, Smee DF, Huffman JH et al. Cyclocreatine (1-carboxymethyl-2- iminoimidazolidine) inhibits the replication of human herpes viruses. Antiviral Res 1994 23 : 203 218.
27. Miller EE, Evans AE, Cohn M. Inhibition of rate of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 1993 90 : 3304 3308.
28. Martin KJ, Winslow ER, Kaddurah-Daouk R. Cell cycle studies of cyclocreatine, a new anticancer agent. Cancer Res 1994 54 : 5160 5165.
29. Ohira Y, Inoue N. Effects of creatine and beta-guanidinopropionic acid on the growth of Ehrlich ascites tumor cells: i.p. injection and culture study. Biochim Biophys Acta 1995 1243 : 367 372.
30. Weil GC, Simon RJ, Sweadner WR. A biological, bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am J Surg 1933 19 : 36 48.
31. Robin Y. Biological distribution of guanidines and phosphagens in marine Annelida and related phyla from California, with a note on pluriphophagens. Comp Biochem Physiol 1964 12 : 347 367.
32. van Pilsum JF, Stephens GC, Taylor D. Distribution of creatine, guanidinoacetate and the enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny. Biochem J 1972 126 : 325 345.
33. Baudin D, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2007 2 : 481 485.